Ghent University Academic Bibliography

Journal Article
A1
open access

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Robert J Kreitman, Claire Dearden, Pier Luigi Zinzani, Julio Delgado, Lionel Karlin, Tadeusz Robak, Douglas E Gladstone, Philipp le Coutre, Sascha Dietrich, Mirjana Gotic, et al.

(2018) LEUKEMIA. 32(8). p.1768-1777

Add to list

Journal Article
A1
open access

Ibrutinib versus temsirolimus : 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

S Rule, W Jurczak, M Jerkeman, C Rusconi, M Trneny, Fritz Offner, D Caballero, C Joao, M Witzens-Harig, G Hess, et al.

(2018) LEUKEMIA. 32(8). p.1799-1803

Add to list

The NF1 hotspot in acute myeloid leukemia : what’s in a name?

Karl Vandepoele (UGent) , Joni Van der Meulen (UGent) and Barbara Denys (UGent)

(2018) LEUKEMIA. 32(12). p.2715-2715

Add to list

Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia

Elaine G Garcia, Sowmya Iyer, Sara P Garcia, Siebe Loontiens (UGent) , Ruslan I Sadreyev, Franki Speleman (UGent) and David M Langenau

(2018) LEUKEMIA. 32(8). p.1860-1865

Add to list

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

C Piette, S Suciu, E Clappier, Y Bertrand, S Drunat, S Girard, K Yakouben, G Plat, N Dastugue, F Mazingue, et al.

(2018) LEUKEMIA. 32(1). p.244-248

Add to list

Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia

Sofie Peirs (UGent) , V Frismantas, Filip Matthijssens (UGent) , W Van Loocke, Tim Pieters (UGent) , Niels Vandamme (UGent) , Béatrice Lintermans (UGent) , MP Dobay, Geert Berx (UGent) , Bruce Poppe (UGent) , et al.

(2017) LEUKEMIA. 31(10). p.2037-2047

Add to list

Leptin receptor antagonism of iNKT cell function : a novel strategy to combat multiple myeloma

Mérédis Favreau (UGent) , E Menu, Djoere Gaublomme (UGent) , K Vanderkerken, S Faict, K Maes, E De Bruyne, Srinath Govindarajan (UGent) , Michael Drennan (UGent) , Serge Van Calenbergh (UGent) , et al.

(2017) LEUKEMIA. 31(12). p.2678-2685

Academic Bibliography

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Ibrutinib versus temsirolimus : 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study

The NF1 hotspot in acute myeloid leukemia : what’s in a name?

Cell of origin dictates aggression and stem cell number in acute lymphoblastic leukemia

Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials

Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia

Leptin receptor antagonism of iNKT cell function : a novel strategy to combat multiple myeloma

Contents

Support

Contact